Metabolic Tests

The Metabolic Syndrome & Glucose Control Panel evaluates key biomarkers—fasting glucose, insulin, lipids, and related metrics—to assess insulin resistance, glucose dysregulation, and cardiometabolic risk. This integrated panel helps clinicians identify metabolic syndrome early, monitor glycemic control, and guide interventions to reduce progression to type 2 diabetes and cardiovascular disease.

The Adiponectin Test measures adiponectin, a hormone made by fat cells that helps regulate glucose levels and fatty acid breakdown. Low adiponectin is linked to insulin resistance, type 2 diabetes, obesity, and cardiovascular disease. Doctors use this test to evaluate metabolic health, assess risk for diabetes or heart disease, and monitor patients with weight-related or endocrine disorders. Results help guide prevention and treatment strategies.

The Albumin Test measures albumin, the main protein made by the liver that maintains fluid balance and transports hormones, vitamins, and medications. Low albumin may indicate liver disease, kidney problems, malnutrition, or chronic inflammation, while high levels may reflect dehydration. Doctors order this test to evaluate swelling, fatigue, or abnormal labs. Results provide key insight into nutritional status, liver and kidney function, and overall metabolic health.

The ALP Test measures alkaline phosphatase enzyme levels in blood to evaluate liver, bone, and bile duct health. High ALP may indicate liver disease, bile duct obstruction, bone disorders, or certain cancers, while low levels may suggest malnutrition or deficiency. Doctors order this test to investigate symptoms like fatigue, abdominal pain, or bone pain and often pair it with other liver function tests. Results provide key insight into metabolic and organ health.

The ALT Test measures alanine aminotransferase, an enzyme mainly found in the liver. Elevated ALT may indicate liver damage from hepatitis, fatty liver disease, cirrhosis, alcohol use, or medication effects. Doctors order this test to evaluate symptoms such as fatigue, abdominal pain, or jaundice and often pair it with AST for accurate liver assessment. Results provide essential insight into liver health, enzyme activity, and overall metabolic function.

The AST Test measures aspartate aminotransferase, an enzyme found in the liver, heart, muscles, and other tissues. Elevated AST may indicate liver disease, heart attack, muscle injury, or other organ damage. Doctors order this test to evaluate symptoms such as fatigue, weakness, or jaundice and often pair it with ALT for accurate liver assessment. Results provide key insight into liver function, muscle health, and overall metabolic balance.

The Basic Metabolic Panel (BMP) Test measures eight markers, including glucose, calcium, sodium, potassium, chloride, carbon dioxide, BUN, and creatinine, to evaluate kidney function, blood sugar, and electrolyte balance. Doctors use this panel to detect diabetes, dehydration, and kidney disease, or to monitor treatment. It is commonly ordered in routine exams, emergency care, or pre-surgical testing to assess overall metabolic and organ health.

The Basic Metabolic Panel Plasma Test measures key blood chemistries including glucose, calcium, sodium, potassium, chloride, carbon dioxide, blood urea nitrogen, and creatinine. These markers provide insight into kidney function, electrolyte balance, and metabolic health. Clinicians often use the results to assess conditions such as dehydration, renal disease, or metabolic disorders and to monitor overall systemic health.

The Bile Acids Fractionated and Total Test measures both individual bile acid fractions and total bile acid concentration to evaluate liver function, bile flow, and metabolic integrity. This analysis helps detect cholestasis, hepatocellular injury, or impaired bile acid metabolism, supporting assessment of liver disorders, intrahepatic cholestasis of pregnancy, and other hepatobiliary conditions.

The Bilirubin Direct Test measures conjugated bilirubin in the blood to assess liver function and bile duct health. Elevated levels may indicate hepatitis, cirrhosis, gallstones, or bile duct obstruction, while low levels are generally normal. Doctors order this test for patients with jaundice, fatigue, or suspected liver disease. Results help diagnose and monitor liver disorders, guide treatment decisions, and evaluate overall hepatic and biliary health.

The Fractionated Bilirubin Test separates total bilirubin into direct and indirect forms to assess liver and blood health. Elevated direct bilirubin may point to hepatitis, cirrhosis, or bile duct obstruction, while elevated indirect levels can signal hemolytic anemia or inherited disorders. Doctors order this test for jaundice, anemia, or suspected liver conditions. Results help guide diagnosis, treatment, and monitoring of liver and blood disorders.

The Bilirubin Total Test measures the overall level of bilirubin in blood to assess liver function, red blood cell breakdown, and bile duct health. Elevated bilirubin may cause jaundice and indicate hepatitis, cirrhosis, gallstones, or hemolytic anemia. Doctors order this test for patients with yellowing skin, fatigue, or abnormal liver results. Results provide essential insight into liver disease, blood disorders, and bile flow problems, guiding diagnosis and treatment.

The Calcium Micronutrient Test measures calcium levels in the blood to assess nutritional status and detect imbalances. Calcium is essential for strong bones and teeth, muscle contraction, nerve signaling, and heart function. This test helps identify deficiencies, excess, or issues with absorption and metabolism, supporting diagnosis and management of bone health, hormonal balance, and overall wellness.

Patient must be 18 years of age or older.

The Calcium Test measures calcium levels in blood to assess bone health, parathyroid function, and metabolic balance. Abnormal levels may indicate bone disease, parathyroid disorders, kidney disease, or certain cancers. Both low and high calcium can cause muscle spasms, weakness, or irregular heartbeat. Doctors order this test to monitor osteoporosis, kidney stones, or endocrine disorders. Results provide essential insight into bone, nerve, and overall metabolic health.

The Heavy Metals Micronutrients Blood Test Panel measures levels of arsenic, cadmium, cobalt, lead, and mercury to assess exposure and potential toxicity. These metals, found in the environment, food, or workplaces, can affect the nervous system, kidneys, bones, and overall health. This panel helps detect harmful accumulation, guide treatment, and monitor risks from environmental or occupational exposure.

Patient must be 18 years of age or older.

The Carbon Dioxide Test measures CO2 levels in the blood to help assess acid-base balance and metabolic function. Abnormal results may reflect respiratory issues, kidney disorders, or metabolic imbalances such as acidosis or alkalosis. This test is often included in electrolyte panels to provide insights into overall health, fluid balance, and how the body maintains proper pH regulation through the respiratory and renal systems.

The Carnitine Test measures carnitine levels in the blood to evaluate fatty acid metabolism and energy production. Abnormal results may indicate primary or secondary carnitine deficiency, often linked to metabolic disorders, malnutrition, or certain medications. Doctors use this test to investigate muscle weakness, hypoglycemia, or developmental delays and to monitor patients receiving treatment for metabolic or mitochondrial disease.

The Chloride Test measures chloride, an essential electrolyte that helps regulate fluid balance, acid-base status, and nerve and muscle function. Abnormal chloride levels may indicate dehydration, kidney disease, metabolic acidosis or alkalosis, or adrenal disorders. By assessing electrolyte balance, this test provides insight into hydration, metabolic function, and overall health of the renal and endocrine systems.

The Chloride Random Urine Test measures chloride levels in a spot urine sample to help evaluate electrolyte and acid-base balance. Abnormal results may indicate dehydration, metabolic alkalosis, renal tubular disorders, or imbalances linked to adrenal gland conditions. This test provides clinical insight into kidney function, metabolic regulation, and systemic fluid balance by detecting changes in urinary chloride excretion.

The Collagen Cross-Linked N-Telopeptide (NTx) 24 Hour Urine Test measures breakdown products of type I collagen, the main protein in bone. Elevated levels reflect increased bone resorption, which may be linked to osteoporosis, metabolic bone disease, or treatment monitoring. This test provides valuable insight into bone turnover, helping evaluate bone health, response to therapy, and risk of skeletal disorders.

The Collagen Cross-Linked N-Telopeptide Urine Test measures type I collagen breakdown products to evaluate bone resorption and skeletal health. Elevated levels may indicate osteoporosis, metabolic bone disease, or increased bone turnover, while lower levels may reflect treatment response. This test provides insight into bone metabolism, helping clinicians assess risk of fractures, monitor therapy, and track long-term bone health.

The Collagen Type I C-Telopeptide (CTX) Test measures CTX fragments released during bone breakdown, making it a key marker of bone resorption. Elevated levels may indicate osteoporosis, metabolic bone disease, or increased fracture risk. Doctors order this test to monitor bone loss, evaluate treatment for osteoporosis, or assess bone health in postmenopausal women. Results provide vital insight into bone turnover and long-term skeletal health management.

The Comprehensive Metabolic Panel (CMP) Test measures 21 markers to assess metabolic health, liver and kidney function, and electrolyte balance. It includes glucose, calcium, sodium, potassium, chloride, CO2, albumin, globulin, A/G ratio, total protein, bilirubin, ALP, AST, ALT, BUN, creatinine, BUN/creatinine ratio, and eGFR. The CMP helps detect diabetes, liver or kidney disease, and supports routine screening and chronic condition monitoring.

The Comprehensive Metabolic Panel (CMP) without ALT evaluates overall metabolic and organ health by measuring glucose, calcium, electrolytes, kidney function markers, and key liver enzymes (excluding ALT). Doctors order this test to assess diabetes, dehydration, kidney disease, or liver dysfunction. Results provide critical insight into metabolic balance, electrolyte disorders, and organ performance, helping guide diagnosis, treatment, and long-term health monitoring.